Wall Street Set to Open Flat in Friday Trading; Import, Export Prices Decline More Than Expected
Investors Look to End Week on Positive Note as US Futures Tread Water in Friday's Premarket Session
Telesis Bio TBIO Delisting; Synaptogenix SNPX Offering
Sector Update: Health Care Stocks Retreat Late Afternoon
Sector Update: Health Care
Nasdaq Surges Over 200 Points; US Crude Oil Stocks Increase
Dow Tumbles 350 Points; US Inflation Rate Slows In August
Top Premarket Decliners
Why Dave & Buster's Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
Stocks to Watch: GameStop, Dave & Buster's, Telesis Bio
Telesis Bio: Expects Last Trading Day of Common Stk on Nasdaq Will Be on or About Sept 30 >TBIO
Telesis Bio: Intends to File a Form 25 With SEC to Remove Common Stk From Listing on Nasdaq on or About Sept 20 >TBIO
Telesis Bio Plans to Delist Its Securities From The Nasdaq Stock Market
Telesis Bio Names CEO Eric Esser as Chair After Five Board Members Resign
Telesis Bio Board Shake-Up: New Chair, Committee Restructuring
Express News | Telesis Bio- Yuan (Terry) Yang Will Purchase Eton Stock for $1.5 Mln
Express News | Telesis Bio- on Aug 14 Entered Share Purchase Agreement With Yuan (Terry) Yang to Sell All of Outstanding Capital Stock of Eton Bio, Inc.
Telesis Bio Shares Are Trading Lower After the Company Reported Worse-than-expected Q2 Financial Results.
Telesis Bio GAAP EPS of -$7.62, Revenue of $1.6M
10-Q: Q2 2024 Earnings Report